(Q34570709)

3 August 2017

1 reference

title

Ki67 protein: the immaculate deception? (English)

1 reference

3 August 2017

Brown DC

1

1 reference

PubMed ID

11903593

3 August 2017

Gatter KC

series ordinal

2

1 reference

3 August 2017

1 January 2002

1 reference

3 August 2017

1 reference

3 August 2017

40

1 reference

3 August 2017

2-11

1 reference

3 August 2017

1

1 reference

Monoclonal antibody Ki-67: its use in histopathology

3 August 2017

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.2002.01343.X

Production of a mouse monoclonal antibody reactive with a human nuclear antigen associated with cell proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.2002.01343.X

Monoclonal antibodies against recombinant parts of the Ki-67 antigen (MIB 1 and MIB 3) detect proliferating cells in microwave-processed formalin-fixed paraffin sections

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.2002.01343.X

Ki-67 expression during rat liver regeneration after partial hepatectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.2002.01343.X

The Ki-67 protein: from the known and the unknown

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.2002.01343.X

The Ki-67 protein: fascinating forms and an unknown function

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.2002.01343.X

The cell proliferation-associated antigen of antibody Ki-67: a very large, ubiquitous nuclear protein with numerous repeated elements, representing a new kind of cell cycle-maintaining proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.2002.01343.X

The FHA domain: a putative nuclear signalling domain found in protein kinases and transcription factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.2002.01343.X

The location of pKi67 in the outer dense fibrillary compartment of the nucleolus points to a role in ribosome biogenesis during the cell division cycle

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.2002.01343.X

Monoclonal antibodies Ki-S3 and Ki-S5 yield new data on the 'Ki-67' proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.2002.01343.X

Which proliferation markers for routine immunohistology? A comparison of five antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.2002.01343.X

Predicting the future: a critical appraisal of cancer prognosis studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.2002.01343.X

Low tumour cell proliferation at the invasive margin is associated with a poor prognosis in Dukes' stage B colorectal cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.2002.01343.X

Determination of proliferative activity in colorectal carcinoma using monoclonal antibody Ki67.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.2002.01343.X

Expression of ras p21, p53 and c-erbB-2 in advanced breast cancer and response to first line hormonal therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.2002.01343.X

Correlation of growth fraction by Ki-67 and proliferating cell nuclear antigen (PCNA) immunohistochemistry with histopathological parameters and prognosis in primary breast carcinomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.2002.01343.X

MIB-1 labelling index is an independent prognostic marker in primary breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.2002.01343.X

The prognostic value of oncogenic antigen 519 (OA-519) expression and proliferative activity detected by antibody MIB-1 in node-negative breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.2002.01343.X

Assessment of the new proliferation marker MIB1 in breast carcinoma using image analysis: associations with other prognostic factors and survival.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.2002.01343.X

Ki67 immunostaining in primary breast cancer: pathological and clinical associations

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.2002.01343.X

Prognostic impact of proliferation-associated factors MIB1 (Ki-67) and S-phase in node-negative breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.2002.01343.X

Comparison of the Ki-67 score and S-phase fraction as prognostic variables in soft-tissue sarcoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.2002.01343.X

A high proliferation rate measured by cyclin A predicts a favourable chemotherapy response in soft tissue sarcoma patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.2002.01343.X

Prognostic significance of the proliferation index in surgically resected non-small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.2002.01343.X

Prognostic biomarker study in pathologically staged N1 non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.2002.01343.X

Hypodiploidy, Ki-67 growth fraction and prognosis of surgically resected lung cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.2002.01343.X

Image cytometric measurement of nuclear proliferation markers (MIB-1, PCNA) in astrocytomas. Prognostic significance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.2002.01343.X

Analysis of proliferation markers and p53 expression in gliomas of astrocytic origin: relationships and prognostic value.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.2002.01343.X

Prognostic indicators in a range of astrocytic tumours: an immunohistochemical study with Ki-67 and p53 antibodies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.2002.01343.X

Prognostication of astrocytoma patient survival by Ki-67 (MIB-1), PCNA, and S-phase fraction using archival paraffin-embedded samples

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.2002.01343.X

Prognostic implications of p53 protein, epidermal growth factor receptor, and Ki-67 labelling in brain tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.2002.01343.X

Ki-67 (clone MIB-1) proliferation index in recurrent glial neoplasms: no prognostic significance

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.2002.01343.X

Accumulation of p53 and Ki-67 expression do not predict survival in patients with fibrillary astrocytomas or the response of these tumors to radiotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.2002.01343.X

MIB-1 (Ki-67) index and transforming growth factor-alpha (TGF alpha) immunoreactivity are significant prognostic predictors for meningiomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.2002.01343.X

MIB 1 immunostaining in stage I squamous cervical carcinoma: relationship with natural killer cell activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.2002.01343.X

Altered expression of mdm-2 and its association with p53 protein status, tumor-cell-proliferation rate and prognosis in cervical neoplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.2002.01343.X

Apoptosis, intrinsic radiosensitivity and prediction of radiotherapy response in cervical carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.2002.01343.X

Carcinoma of the cervix uteri: an assessment of the relationship of tumour proliferation to prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.2002.01343.X

Tumor cell proliferation and survival in patients with prostate cancer followed expectantly

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.2002.01343.X

Prognostic significance of Ki-67, p53, and Bcl-2 expression in prostate cancer patients with lymph node metastases: a retrospective immunohistochemical analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.2002.01343.X

Protein expression of p53, bcl-2, and KI-67 (MIB-1) as prognostic biomarkers in patients with surgically treated, clinically localized prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.2002.01343.X

Ki-67 expression is a prognostic marker of prostate cancer recurrence after radical prostatectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.2002.01343.X

Pathological and clinical associations of Ki-67 defined growth fractions in human prostatic carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.2002.01343.X

An evaluation of the markers p53 and Ki-67 for their predictive value in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.2002.01343.X

Assessment of the biologic markers p53, Ki-67, and apoptotic index as predictive indicators of prostate carcinoma recurrence after surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.2002.01343.X

Evaluation of multiple bio-pathological factors in colorectal adenocarcinomas: independent prognostic role of p53 and bcl-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.2002.01343.X

Ki-67-determined growth fraction versus standard staging and grading parameters in colorectal carcinoma. A multivariate analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.2002.01343.X

Apoptosis and immunohistochemical bcl-2 expression in colorectal adenomas and carcinomas. Aspects of carcinogenesis and prognostic significance

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.2002.01343.X

Immunohistochemical assessment of Ki67 and p53 expression assists the diagnosis and grading of ulcerative colitis-related dysplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.2002.01343.X

Distinction of basaloid carcinoma of the prostate from benign basal cell lesions by using immunohistochemistry for bcl-2 and Ki-67.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.2002.01343.X

Immunohistochemical evaluation of basal cell carcinoma and trichepithelioma using Bcl-2, Ki67, PCNA and P53.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.2002.01343.X

Clinical significance of cyclin-dependent kinase inhibitor p27Kip1 expression and proliferation in non-Hodgkin's lymphoma: independent prognostic value of p27Kip1

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.2002.01343.X

Hepatitis delta genotypes in chronic delta infection in the northeast of Spain (Catalonia)

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.2002.01343.X

10.1046/J.1365-2559.2002.01343.X

21 January 2018

Identifiers

DOI

1 reference

3 August 2017

1 reference

PubMed ID

11903593